Bruton Tyrosine Kinase (BTK) inhibitor

News

Novel drug to tackle inflammatory diseases begins trial

An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the US regulator.

News

Novo Nordisk gets FDA okay for Wegovy pill

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of its Wegovy pill.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Bruton Tyrosine Kinase (BTK) inhibitor

Editor's Picks